Uncertain about uncertainty in matching-adjusted indirect comparisons? A simulation study to compare methods for variance estimation

被引:0
|
作者
Chandler, Conor O. [1 ]
Proskorovsky, Irina [1 ]
机构
[1] Evidera, Evidence Synth Modeling & Commun, 7101 Wisconsin Ave, Bethesda, MD 20814 USA
关键词
bootstrap; matching-adjusted indirect comparison; robust sandwich estimator; simulation study; uncertainty; variance; MARGINAL STRUCTURAL MODELS; BAYESIAN-ESTIMATION; TARGET ESTIMANDS; HETEROSKEDASTICITY; INFERENCE; SURVIVAL; METAANALYSIS;
D O I
10.1002/jrsm.1759
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In health technology assessment, matching-adjusted indirect comparison (MAIC) is the most common method for pairwise comparisons that control for imbalances in baseline characteristics across trials. One of the primary challenges in MAIC is the need to properly account for the additional uncertainty introduced by the matching process. Limited evidence and guidance are available on variance estimation in MAICs. Therefore, we conducted a comprehensive Monte Carlo simulation study to evaluate the performance of different statistical methods across 108 scenarios. Four general approaches for variance estimation were compared in both anchored and unanchored MAICs of binary and time-to-event outcomes: (1) conventional estimators (CE) using raw weights; (2) CE using weights rescaled to the effective sample size (ESS); (3) robust sandwich estimators; and (4) bootstrapping. Several variants of sandwich estimators and bootstrap methods were tested. Performance was quantified on the basis of empirical coverage probabilities for 95% confidence intervals and variability ratios. Variability was underestimated by CE + raw weights when population overlap was poor or moderate. Despite several theoretical limitations, CE + ESS weights accurately estimated uncertainty across most scenarios. Original implementations of sandwich estimators had a downward bias in MAICs with a small ESS, and finite sample adjustments led to marked improvements. Bootstrapping was unstable if population overlap was poor and the sample size was limited. All methods produced valid coverage probabilities and standard errors in cases of strong population overlap. Our findings indicate that the sample size, population overlap, and outcome type are important considerations for variance estimation in MAICs.
引用
收藏
页码:1094 / 1110
页数:17
相关论文
共 50 条
  • [11] Uncertainty in Matching-Adjusted Indirect Comparisons Using Real-World Evidence: Evidence Assessment Group Perspective
    Uteh, Cyril Onwuelazu
    Johnson, Eugenie Evelynne
    Robinson, Tomos
    Moradi, Najmeh
    Inskip, Alex
    Beyer, Fiona R.
    Thomson, Katie
    Sagoo, Gurdeep S.
    PHARMACOECONOMICS, 2025, : 469 - 472
  • [12] Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
    Signorovitch, James E.
    Sikirica, Vanja
    Erder, M. Haim
    Xie, Jipan
    Lu, Mei
    Hodgkins, Paul S.
    Betts, Keith A.
    Wu, Eric Q.
    VALUE IN HEALTH, 2012, 15 (06) : 940 - 947
  • [13] POPULATION-ADJUSTED TREATMENT COMPARISONS: ESTIMATES BASED ON MAIC (MATCHING-ADJUSTED INDIRECT COMPARISONS) AND STC (SIMULATED TREATMENT COMPARISONS)
    Phillippo, D. M.
    Ades, A.
    Dias, S.
    Palmer, S.
    Abrams, K. R.
    Welton, N. J.
    VALUE IN HEALTH, 2017, 20 (05) : A339 - A339
  • [14] Geometric approaches to assessing the numerical feasibility for conducting matching-adjusted indirect comparisons
    Glimm, Ekkehard
    Yau, Lillian
    PHARMACEUTICAL STATISTICS, 2022, 21 (05) : 974 - 987
  • [15] REVIEW OF NICE HTA SUBMISSIONS INCLUDING MATCHING-ADJUSTED INDIRECT COMPARISONS AND SIMULATED TREATMENT COMPARISONS
    Muresan, B.
    Hu, Y.
    Postma, M. J.
    Ouwens, M. J.
    Heeg, B.
    VALUE IN HEALTH, 2018, 21 : S24 - S24
  • [16] Synthesis of Matching-Adjusted Indirect Comparisons of Ozanimod for Relapsing Remitting Multiple Sclerosis
    Paul, D.
    Swallow, E.
    Patterson-Lomba, O.
    Branchcomb, T.
    Gomez-Lievano, A.
    Liu, J.
    Dua, A.
    McGinley, M.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 47 - 47
  • [17] Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ocrelizumab, and Interferon beta-1a
    Hersh, Carrie
    Aladro-Benito, Yolanda
    Lewin, James B.
    Shen, Changyu
    Bozin, Ivan
    Sun, Zhaonan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 641 - 641
  • [18] Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis
    Jiang, Tammy
    Ziemssen, Tjalf
    Wray, Sibyl
    Shen, Changyu
    Soderbarg, Karin
    Lewin, James B.
    Bozin, Ivan
    Freedman, Mark S.
    CNS DRUGS, 2023, 37 (05) : 441 - 452
  • [19] Matching-adjusted indirect comparisons of ixekizumab and secukinumab using etanercept and ustekinumab bridge comparators
    Wu, J. J.
    Saure, D.
    Schacht, A.
    Mallbris, L.
    Wilhelm, S.
    Dossenbach, M.
    Burkhardt, N.
    Nast, A.
    Warren, R. B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 44 - 44
  • [20] Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis
    Tammy Jiang
    Tjalf Ziemssen
    Sibyl Wray
    Changyu Shen
    Karin Söderbärg
    James B. Lewin
    Ivan Božin
    Mark S. Freedman
    CNS Drugs, 2023, 37 : 441 - 452